about
sameAs
Multilocus analysis of SNP and metabolic data within a given pathway.Pathway based analysis of SNPs with relevance to 5-FU therapy: relation to intratumoral mRNA expression and survival.TETRABENAZINE (NITOMAN) IN THE TREATMENT OF PSYCHOSES. WITH A DISCUSSION ON THE CENTRAL MODE OF ACTION OF TETRABENAZINE AND RESERPINEIndividual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumorsInhibitory effect of ethanol on 5-hydroxytryptamine (serotonin) uptake in human blood platelets in vitroA systematic comparison of copy number alterations in four types of female cancerCopynumber: Efficient algorithms for single- and multi-track copy number segmentation.Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression dataIdentifying clusters in genomics data by recursive partitioning.CGH-Explorer: a program for analysis of array-CGH data.Predicting survival from microarray data--a comparative study.Partial least squares Cox regression for genome-wide data.Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors.Merging transcriptomics and metabolomics--advances in breast cancer profiling.Combining gene signatures improves prediction of breast cancer survival.Linear and non-linear dependencies between copy number aberrations and mRNA expression reveal distinct molecular pathways in breast cancer.Landscape of somatic mutations in 560 breast cancer whole-genome sequences.Allele-specific copy number analysis of tumors.Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density.Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue.[Imiprex "Dumex" (imipramine oxide). A new tricyclic antidepressive agent]Biologically active peptide-containing fractions in schizophrenia and childhood autism.Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations.Noxiptilin (Agedal)--a new tricyclic antidepressant with a faster onset of action? A double-blind, multicentre comparison with amitriptyline.High levels of genomic aberrations in serous ovarian cancers are associated with better survival.A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancerSystematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status.The multitude of molecular analyses in cancer: the opening of Pandora’s box.Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancerGene expression profiles of breast biopsies from healthy women identify a group with claudin-low features.Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.Canine Mammary Tumours Are Affected by Frequent Copy Number Aberrations, including Amplification of MYC and Loss of PTENReport on the third consensus conference on the methodology of clinical trials with antipsychotic drugs.Benzodiazepines in the treatment of schizophrenia: an updated survey.Metabolic clusters of breast cancer in relation to gene- and protein expression subtypesGlycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progressionGenomic architecture characterizes tumor progression paths and fate in breast cancer patients.Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome.Blood platelets as a model system for studying serotonergic dysfunction and effects of antidepressants.Consensus Conference on the Methodology of Clinical Trials of "Nootropics", Munich, June 1989. Report of the Consensus Committee.
P50
Q25256821-AD2583CA-AB6A-4F9F-BDD4-AFA55A89366CQ27863385-F7340D1E-5858-4E27-B67B-A0AE56C1F34EQ28155925-FDB76E65-006E-4402-8228-7A70F1C93125Q28302352-A05EB31B-BF79-4E28-A2F6-035A7B18127AQ28329319-BB9B5AA6-D9E6-4A0D-B59C-00D05ED0DEF3Q28394747-18BC6AAC-E8FC-4DA8-A5B1-33F4F6578957Q30536665-80EEB45B-EC3A-4C82-B560-3FB70CA58F74Q30587051-3FF71141-C88E-46CD-AF23-E81CD7F5407FQ30661286-EA4C04D5-65B7-4E03-AA70-42975E72EE93Q30975681-9B490205-6421-4E1C-B6F6-656FEC4C9334Q31114975-2E18AC55-8123-45EB-8323-91AB2635E1C1Q31142534-9EE690AF-89EF-4FBF-A800-0A004CCC0439Q33358940-906DE02C-4CE8-4E20-BF6F-1CDFCA220109Q33748176-BE177036-92DA-48CD-954F-C7358A58660BQ33851725-E89AA961-AC46-498F-AE94-0253588809CFQ33910433-1FC3A7F2-718D-4200-9DBF-2E0FD2494F77Q34046731-639D21C5-4A0E-4E72-BF4B-DB2FC9802937Q34165640-74C91EDA-B423-4E18-9CD0-C45A0F6D650AQ34173591-E02B7A5C-1721-4E42-8CBB-3573BDBCE93AQ34216309-3095B371-F365-4290-B93D-0ED7AFDAC0BEQ34228943-32D3D082-2FAF-4CDC-9693-93AC8547F905Q34275734-DBF968DC-D9F6-4FC1-8D37-DECE0EDAC1BEQ34291133-F470EE6E-B597-44CA-B866-102B202FCEDDQ34320223-4AA83BC3-FB21-4106-B61A-6AF0131E744DQ34571142-2656E1F9-6D33-4673-9FAB-D1300F68132AQ34854883-BFB33674-CF6F-4AB1-ADDC-CA0C6F240244Q35124596-2568FDAA-0809-4685-835E-360F167DA4E5Q35332888-2FB9F8A9-7B5B-4A13-A157-6543100BE770Q35410361-9384C131-F9AD-4D95-9A65-62825FBB44B3Q35551926-17844FA0-5182-492C-9642-B6AA4133D94AQ35579053-A4E4F88F-70D4-4D7B-9153-3D3B43EC6F11Q35587062-41200052-9609-42BD-9E6F-6F498D6A28A7Q36541648-B1382AD6-F122-409C-877F-A2AC5A0DF9F9Q36541738-DC67B01E-B9D1-4462-AB82-BFFD8B89A3A4Q37040438-A0DAB37E-ADCA-456C-A63E-A06BA1597220Q37671122-4C926F44-097B-4E2C-AD71-DDD9565991D3Q37678826-76A3C6D4-DBA0-4604-BA4D-546C31E416FEQ37728699-022D3247-B750-4514-9B43-B51182DFF96BQ37907750-949B4762-D118-4759-B8AC-7A77B56D28D3Q37945981-635DFE30-7FF2-481B-9D32-30F9ED7AB772
P50
description
Noors onderzoeker
@nl
Norwegian researcher
@en
norsk professor
@nb
taighdeoir Ioruach
@ga
հետազոտող
@hy
name
Ole Christian Lingjærde
@an
Ole Christian Lingjærde
@ast
Ole Christian Lingjærde
@ca
Ole Christian Lingjærde
@da
Ole Christian Lingjærde
@de
Ole Christian Lingjærde
@en
Ole Christian Lingjærde
@es
Ole Christian Lingjærde
@eu
Ole Christian Lingjærde
@fr
Ole Christian Lingjærde
@ga
type
label
Ole Christian Lingjærde
@an
Ole Christian Lingjærde
@ast
Ole Christian Lingjærde
@ca
Ole Christian Lingjærde
@da
Ole Christian Lingjærde
@de
Ole Christian Lingjærde
@en
Ole Christian Lingjærde
@es
Ole Christian Lingjærde
@eu
Ole Christian Lingjærde
@fr
Ole Christian Lingjærde
@ga
altLabel
Ole C Lingjaerde
@en
Ole Christian Lingjaerde
@en
prefLabel
Ole Christian Lingjærde
@an
Ole Christian Lingjærde
@ast
Ole Christian Lingjærde
@ca
Ole Christian Lingjærde
@da
Ole Christian Lingjærde
@de
Ole Christian Lingjærde
@en
Ole Christian Lingjærde
@es
Ole Christian Lingjærde
@eu
Ole Christian Lingjærde
@fr
Ole Christian Lingjærde
@ga
P1015
P1015
P106
P1153
35446149600
P21
P214
78145970331032252326
P2287
P27
P31
P496
0000-0003-3565-4912
P569
1965-01-01T00:00:00Z
P734
P735
P7859
viaf-78145970331032252326